Swipe om te navigeren naar een ander artikel
Empirically conducted studies of the efficacy of various treatments for autism are limited, which leaves parents with little evidence on which to base their treatment decisions (Kasari, Journal of Autism and Developmental Disorders, 32: 447–461, 2002). The purpose of this study was to examine the types of treatments in current use by families of children with ASD. In addition, parents’ perceptions of improvement in their child’s functioning were explored. Through an online survey, a sample of 970 parents of ASD children reported on the treatments currently in use, those discontinued, and reasons for discontinuation. Results indicate that most families adopt multiple treatment approaches. Parents were most likely to discontinue non-evidence based treatments when they did not see improvement in their child’s functioning.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders IV-TR (text revision). Washington, DC: American Psychiatric Association. CrossRef
Campbell, M., Schopler, E., Cueva, J. E., & Hallin, A. (1996). Treatment of autistic disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 35, 134–143. CrossRef
Dillenburger, K., Keenan, M., Gallagher, S., & McElhinney, M. (2004). Parent education and home-based behaviour analytic intervention: an examination of parents’ perceptions of outcome. Journal of Intellectual & Developmental Disability, 29, 119–130. CrossRef
Fombonne, E. (2005). Epidemiological studies of pervasive developmental disorders. In F. R. Volkmar, R. Paul, A. Klin, & D. Cohen (Eds.), Handbook of autism and pervasive developmental disorders (pp. 42–69). Hoboken, NJ: John Wiley & Sons, Inc.
Goin-Kochel, R. P., Mackintosh, V. H., & Myers, B. J. (2009). Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders. Research in Autism Spectrum Disorders, 3, 528–537. CrossRef
Goin-Kochel, R. P., Myers, B. J., & Mackintosh, V. H. (2007). Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Research in Autism Spectrum Disorders, 1, 195–209. CrossRef
Green, V. A. (2007). Parental experience with treatments for autism. Journal of Developmental Physical Disabilities, 19, 91–101. CrossRef
Heflin, L. J., & Simpson, R. L. (1998). Interventions for children and youth with autism: Prudent choices in a world of exaggerated claims and empty promises. Part 1: Intervention and treatment option review. Focus on Autism and Other Developmental Disabilities, 13, 194–211. CrossRef
Hume, K., Bellini, S., & Pratt, C. (2005). The usage and perceived outcomes of early intervention and early childhood programs for young children with autism spectrum disorder. Topics in Early Childhood Special Education, 25, 195–207. CrossRef
Kern, J. K., Espinoza, E., & Trivedi, M. (2004). The effectiveness of secretin in the management of autism. Expert Opinion Pharmacotherapy, 5, 379–387. CrossRef
Levy, S. E., & Hyman, S. L. (2002). Alternative/Complementary approaches to treatment of children with autism spectrum disorders. Infants and Young Children, 14, 33–42. CrossRef
Levy, S. E., & Hyman, S. L. (2005). Novel treatments for autistic spectrum disorders. Mental Retardation and Developmental Disabilities, 11, 131–142. CrossRef
Lord, C., & Schopler, E. (1988). Intellectual and developmental assessment of autistic children from preschool to school age: Clinical implications of two follow-up studies. In G. Mesibov & E. Schopler (Eds.), Diagnosis and assessment in Autism (pp. 167–181). New York, NY: Plenum Press.
Metz, B., Mulick, J. A., & Butter, E. M. (2005). Autism: A late-20th–century fad magnet. In J. W. Jacobson, R. M. Foxx, & J. A. Mulick (Eds.), Controversial therapies for developmental disabilities: Fad, fashion and science in professional practice (pp. 237–263). Mahwah, NJ: Lawrence Erlbaum Associates.
New York State Department of Health Early Intervention Program (1999). Clinical practice guidelines: Report of the recommendations on autism and pervasive developmental disorders. New York: State Department of Health. Retrieved March 23, 2005 from www.health.state.ny.us/nysdoh/eip/menu.htm.
Smith, T. (1999). Outcome of early intervention for children with autism. Clinical Psychology: Science and Practice, 6, 33–49. CrossRef
Tharp, B. (2003). Contributions of neurology. In S. Ozonoff, S. J. Rogers, & R. L. Hendren (Eds.), Autism spectrum disorders: A research review for practioners (pp. 111–129). Washington, DC, USA: American Psychiatric Publishing, Inc.
Tidmarsh, L., & Volkmar, F. R. (2003). Diagnosis and epidemiology of autism spectrum disorders. Canadian Journal of Psychiatry, 48, 517–525. (electronic version).
Volkmar, F. R., & Klin, A. (2005). Autism in infancy and early childhood. Annual Reviews of Psychology, 56, 315–336. CrossRef
Yung, W. H., Leung, P. S., Ng, S. S., Zhang, J., Chan, S. C., & Chow, B. K. (2001). Secretin facilitates GABA transmission in the cerebellum. Journal of Neuroscience, 21, 7063–7068. PubMed
- Treatments for Autism: Parental Choices and Perceptions of Change
Nadia M. D’Angelo
- Springer US